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Chemicals were from Sigma-Aldrich. Isoquinolines (3) ((S)-2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido)-3-(1H-indol-3-yl)propanoic acid) and (4) ((R)-2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido)-3-(1H-indol-3-yl)propanoic acid) were synthesized according to the reported procedure 1 . Thiol (2) was synthesized as described 2 .
Mutagenesis
The M67C NDM-1 variant was generated using the δ36 NDM-1 in the pOPINF plasmid as described 1 . The desired point mutation was achieved employing the QuikChange sites directed mutagenesis kit (Stratagene) using the following primers: forward -5ˈ-GGCAGCATACCAGCTATCTGGATTGCCCTGGTTTTGGTGCAG, reverse -5ˈ-CTGCACCAAAACCAGGGCAATCCAGATAGCTGGTATGCTGCC.
Optimisation of protein expression system
In order to obtain a high-yield protein expression system to produce the NDM-1 M67C mutant first the same expression system was applied that we used to produce the wild type NDM-1. ref (Namely/In details: The recombinant NDM-1 were produced in E. coli BL21(DE3) pLysS cells using 2TY media supplemented with 50 μg/ml ampicillin and 34 μg/ml chloramphenicol. Cells were grown at 37 °C until the OD 600 reached 0.6 -0.7. After that the temperature was lowered to 20 °C and the cells were induced with 0.5 mM IPTG. The cells were further incubated for 20h before harvested). Using the wild type NDM-1 expression system low expression of the NDM-1 M67C mutant was obtained (< 0.5 mg/L of culture), which was not suitable for us and therefore we decided to optimize the expression system. During the optimization process the expression level was judged by the SDS page that contained the lysate of the cells obtained from the lysis with the BugBuster kit.
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To improve the expression level we tried to use different temperatures (37, 28 and 18 ºC), various IPTG levels (0, 0.1, 0.25, 0.5 and 1mM final IPTG) and different incubation times (4 and 20h), but in all cases low expression levels were obtained. We also tried to use normal BL21(DE3) cells, made the IPTG induction at higher OD (~ 1.3) or made the expression of the NDM-1 M67C mutant in the presence of 50 μg/ml ZnSO 4 , but the expression level was not significantly improved. Next, we also tried to use other media such as the Terrific Broth (TB media, using a 0.5 mM IPTG) and the Studier autoinduction media to improve the expression level. During the expression trials using TB and autoinduction media we also tried different temperatures (37, 28 and 18 ºC). A significantly improved level of expression was obtained by using the autoinduction media at 18 ºC.
Protein production and purification
Recombinant NDM-1 M67C was produced in E. coli BL21 (DE3) pLysS cells using Studier autoinduction media 3 supplemented with 50 μg/ml ampicillin and 50 μg/ml chloramphenicol. The medium was modified by addition of MgSO 4 and ZnSO 4 , to ensure the protein was obtained as diZn(II) complex (the Studier autoinduction media contains various metals salts and using original recipe different metal-NDM-1 complexes were obtained). Cells were grown at 37 ºC for 4 h, then the temperature was reduced to 18 ºC for 20h. Cell were harvested by centrifugation (10 min, 8000 rpm) and NDM-1 M67C was purified as reported 1 . FPLC chromatograms and SDS-page gels from the NDM-1 M67C purification are shown in Fig. S3 .
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NDM-1 M67C labelling NDM-1 M67C was treated with tris-(2-carboxyethyl)phosphine (TCEP, final concentration 2 mM), then incubated on ice (5 min) and buffered exchanged into phosphate buffer (50 mM, pH 7.0, 200 mM NaCl). A concentrated stock of 100 mM 3-bromo-1,1,1-trifluoroacetone reagent in phosphate buffer was prepared freshly prior to the reaction. NDM-1 M67C sample (0.15 mM) was treated with 3-bromo-1,1,1-trifluoroacetone (final concentration 2 mM) and incubated for 10 min at room temperature, prior to buffer exchange into Tris buffer (50 mM, pH 7.5, 200 mM NaCl). Buffer exchanges were performed using a PD-10 desalting column (GE Healthcare).
Kinetic analyses
Kinetic and inhibition analyses were performed as described 1 . K M measurements were performed using 0.5 nM NDM-1 and 1 nM NDM-1* for meropenem measurements and 0.25 nM NDM-1 and 2 nM NDM-1* for nitrocefin measurements.
NMR experiments
NMR measurements were conducted using a Bruker AVII 500 spectrometer equipped with a 5mm zgradient triple resonance inverse 1 S11 ).
Metal binding experiments
Apo NDM-1* was obtained by incubation of the NDM-1*-2Zn(II) complex with 10 mM EDTA in Tris buffer (50 mM pH 7.5) supplemented with 200 mM NaCl (12 h, 4°C). The solution was then buffer exchanged into fresh Tris buffer (50 mM pH 7.5) supplemented with 200 mM NaCl to remove excess EDTA. Samples for metal titrations were containing 70 µM NDM-1* and 50 µM TFA as an internal standard. Figure S1 . Overall fold of NDM-1-2Zn(II) complex. Note the L1 loop, which was labelled in our studies, flanks the NDM-1 active site. The figure was generated using a di-Zn(II)-NDM-1 complex crystal structure (PDB id: 3SPU) 4 . 
Tryptic digest and MS/MS analysis

In-Solution Digestion
All reagents were prepared in 100 mM Tris buffer, pH 7.8. Samples (< 500 µg) were dried in a Vacufuge® vacuum concentrator (Eppendorf) connected to an external diaphragm pump and then resuspended in 100 µl of 6 M urea. Disulfides were reduced at room temperature (30 min) by addition of 5 µl of 200 mM dithiothreitol (DTT), and subsequently alkylated at room temperature (30 min) with 30 µl of 200 mM iodoacetamide. Unreacted alkylating reagent was consumed by addition of 30 µl DTT solution (30 min). The sample was then diluted with 775 µl Tris buffer, mixed with Sequencing Grade Modified Porcine Trypsin (Promega) at trypsin:protein sample ratio of ca. 1:50, and digested at 37°C for 12h. Digestion was stopped by adjusting the sample to pH 3-4 by addition of concentrated acetic acid. Digested samples were subsequently purified and desalted by solid-phase extraction using Sep-Pak C 18 Plus Light Cartridges (Waters, 130 mg sorbent per cartridge, 55-105 µM particle size) following the manufacturer's protocol. The samples were then dried using a Vacufuge® and subsequently re-dissolved in typically 15-30 µl of 50% CH 3 CN/0.1% CF 3 COOH for analysis by MALDI-ToF-MS.
MALDI-ToF-MS and MS/MS studies
Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-ToF-MS) and MS/MS analyses were performed using a Bruker Daltonics Ultraflex™ MALDI-ToF/ToF machine, using flexControl™ 3.0 software. Spectra were recorded in the positive ion reflectron mode, typically with 32-38% laser energy. Calibration was performed on each day prior to the measurements using Peptide Calibration Standard II (Bruker Daltonics). Data were processed using Bruker Daltonics flexAnalysis™ 3.0 software and assigned manually. For MALDI measurements, 1 µl of the sample was mixed with 4 µl of 2,5-dihydroxybenzoic acid (DHB, 20 mg/ml in 50% CH 3 CN/0.1% CF 3 COOH) matrix and 2 µl of this sample-matrix mixture spotted onto a 24 x 16 MTP AnchorChip™ 384 T F MALDI target and allowed to air-dry before analysis. 
